Annexin‐A5 and annexin‐A6 silencing prevents metastasis of breast cancer cells in zebrafish

Author:

Gounou Céline1,Bouvet Flora1,Liet Benjamin2,Prouzet‐Mauléon Valérie23,d'Agata Léna1,Harté Etienne4,Argoul Françoise4ORCID,Siegfried Géraldine2,Iggo Richard2,Khatib Abdel‐Majid256,Bouter Anthony1ORCID

Affiliation:

1. Univ. Bordeaux, CNRS Bordeaux INP, CBMN, UMR 5248 Pessac France

2. Univ. Bordeaux INSERM, BRIC, U 1312 Bordeaux France

3. CRISPRedit TBMcore, UAR CNRS 3427, Inserm US 005, Univ Bordeaux France

4. Univ. Bordeaux CNRS, LOMA, UMR 5798 Talence France

5. XenoFish, B2 Ouest, Allée Geoffroy St Hilaire CS50023 Pessac France

6. Bergonié Institute Bordeaux France

Abstract

AbstractBackground InformationDuring tumor invasion and metastasis processes, cancer cells are exposed to major compressive and shearing forces, due to their migration through extracellular matrix, dense cell areas, and complex fluids, which may lead to numerous plasma membrane damages. Cancer cells may survive to these mechanical stresses thanks to an efficient membrane repair machinery. Consequently, this machinery may constitute a relevant target to inhibit cancer cell dissemination.ResultsWe show here that annexin‐A5 (ANXA5) and ANXA6 participate in membrane repair of MDA‐MB‐231 cells, a highly invasive triple‐negative breast cancer cell line. These crucial components of the membrane repair machinery are substantially expressed in breast cancer cells in correlation with their invasive properties. In addition, high expression of ANXA5 and ANXA6 predict poor prognosis in high‐grade lung, gastric, and breast cancers. In zebrafish, the genetic inhibition of ANXA5 and ANXA6 leads to drastic reduction of tumor cell dissemination.ConclusionWe conclude that the inhibition of ANXA5 and ANXA6 prevents membrane repair in cancer cells, which are thus unable to survive to membrane damage during metastasis.SignificanceThis result opens a new therapeutic strategy based on targeting membrane repair machinery to inhibit tumor invasion and metastasis.

Publisher

Wiley

Subject

Cell Biology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3